Condition
Primary Progressive Aphasia(PPA)
Total Trials
8
Recruiting
5
Active
6
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 8 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Recruiting5
Enrolling By Invitation1
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (8)
Showing 8 of 8 trials
NCT07260253Not ApplicableRecruitingPrimary
Remotely-supervised Neuromodulation in PPA
NCT07567664Not ApplicableEnrolling By Invitation
Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases
NCT07158216Not ApplicableRecruitingPrimary
Long Term Effect of Brain Stimulation in PPA
NCT07219680Not ApplicableRecruitingPrimary
Intervention for Communication Quality of Life in Primary Progressive Aphasia
NCT06739967RecruitingPrimary
Speech and Language Interventions for Italian People With PPA
NCT04715399Recruiting
UPenn Observational Research Repository on Neurodegenerative Disease
NCT06870838Active Not Recruiting
Neuroinflammation in FTLD
NCT06921265Not ApplicableNot Yet RecruitingPrimary
Targeted Transcranial Magnetic Stimulation to Improve Language and Speech in Patients With Primary Progressive Aphasia
Showing all 8 trials